Nanomedicine & Drug Delivery

About the Conference

                                   34^th International Conference on Nanomedicine & Drug Delivery

                                                                           September 17–18, 2026
                                                                   Venue: London, United Kingdom

                            Theme: “Advancing Precision Nanotherapeutics & Smart Drug Delivery Systems”

The 34th International Conference on Nanomedicine & Drug Delivery (Nanomedicine-2026) is a premier global platform bringing together leading scientists, researchers, clinicians, pharmaceutical professionals, nanotechnology experts, and industry innovators.

This two-day international forum will showcase cutting-edge research, emerging technologies, and translational advancements in nanomedicine and advanced drug delivery systems. Nanomedicine-2026 aims to bridge academia and industry to accelerate the transformation of nanoscale innovations into real-world therapeutic solutions.

About Organizing

Conferenceseries LLC Ltd is the world’s leading expert in organizing academic, scientific, and business conferences, meetings, symposia, and exhibitions across diverse disciplines—including medicine, pharmacy, engineering, science, technology, and business—aimed at advancing scientific research. With the valued support of over 30,000 editorial board members and partnerships with more than 1,000 scientific societies, we host more than 3,000 international events annually. These include over 1,000 conferences, symposia, and workshops across the United States, Europe, the Middle East, and Asia. All conference proceedings are published in special issues of our 700+ international open access journals, with DOIs assigned by CROSSREF to ensure global citation and accessibility.

Why to Attend Nanomedicine-2026?

• Gain insights from internationally recognized keynote speakers
• Present your research to a global scientific audience
• Network with experts from academia and pharmaceutical industries
• Explore collaborations and funding opportunities
• Learn about regulatory updates and commercialization pathways

Who Should Attend?

• Researchers & Academicians
• Pharmaceutical & Biotech Professionals
• Nanotechnology Scientists
• Clinical Researchers
• Regulatory Experts
• Postdoctoral Fellows & Graduate Students
• Healthcare Innovators & Startups

Call for Abstracts

We invite researchers, scientists, and industry professionals to submit abstracts for Oral and Poster Presentations.

• Abstract Submission Deadline: March 15, 2026
• Early Bird Registration Deadline: April 10, 2026

All accepted abstracts will be reviewed by our Scientific Committee. Selected high-quality papers may be recommended for publication in associated indexed journals.

Conference Highlights

• Keynote & Plenary Sessions
• Oral & Poster Presentations
• Industry Exhibitions
• Young Researcher Awards
• Networking & Collaboration Opportunities

Scientific Sessions & Tracks

Track 1: Nanomedicine

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology in the prevention and treatment of diseases. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and Nano robots, for diagnosis, delivery, sensing or actuation purposes in a living organism.  The physicochemical and biological properties of the Nanoparticles can also be finely adjusted by tailoring their chemical properties, sizes, shapes, structures, morphologies, and surface properties. Nanomedicine is the medical application of Nanotechnology. Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials.

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices in the near future. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced drug delivery systems, new therapies, and in vivo imaging.

Track 2: Drug Delivery system

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic outcome. The field of drug delivery has advanced dramatically in the past few decades, and even greater innovations are anticipated in the coming years. Biomedical engineers have contributed substantially to our understanding of the physiological barriers to efficient drug delivery and have also contributed to the development of several new modes of drug delivery that have entered clinical practice.

Track 3: Pharmaceutical nanotechnology

Pharmaceutical nanotechnology is the exciting, rapidly emerging branch of medical science that deals with harnessing nanoscale materials as drug delivery and/or diagnostic tools. As drug delivery tools, nano-delivery systems can be used to enhance the site-specific, targeted delivery of precise medicines.

Pharmaceutical Nanotechnology based system deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Track 4: Nanorobotics and Nanomedicine

Nanomedicine will be based on the ability to build Nanorobots. In the future these Nanorobots could actually be programmed to repair specific diseased cells, functioning in a similar way to antibodies in our natural healing processes. The motivation for the new manipulation technology is the desire to enter the micro and Nanoworld not only by viewing but also acting, altering micro- and nanosized objects. A new era on medicine are expected to happen in the coming years. Due to the advances in the field of Nanotechnology, Nanodevice manufacturing has been growing gradually. The elimination of bacterial infections in a patient within minutes, instead of using treatment with antibiotics over a period of weeks.

Track 5: Smart Drug Delivery Technology

The development of the smart drug delivery system (SDDS) is a revolution of nanotechnology in the pharmaceutical and medical fields. Nanomaterials through their enhanced target specificity, biodistribution, and plasma retention have overcome the therapeutic adverse effects of the conventional drug delivery system. The response-based intelligence of the system helps to release drug payloads released under specific pathological conditions. The development of an intelligent drug delivery system combines multiple approaches and multiple signal responses to improve their applicability in diagnosis as well as therapy.

Track 6: Nanorobotics

Nanomedicine will be based on the ability to build Nanorobots. In the future these Nanorobots could actually be programmed to repair specific diseased cells, functioning in a similar way to antibodies in our natural healing processes. The motivation for the new manipulation technology is the desire to enter the micro- and Nanoworld not only by viewing but also acting, altering micro- and nanosized objects. A new era on medicine are expected to happen in the coming years. Due to the advances in the field of Nanotechnology, Nanodevice manufacturing has been growing gradually. The elimination of bacterial infections in a patient within minutes, instead of using treatment with antibiotics over a period of weeks.

Track 7: Computational studies in Nanoparticles

The computational studies in nanoparticles have demonstrated that there has been considerable progress in Nano and biotechnology in the last several years. However, several key challenges have also become apparent, including the need for a better understanding of nanoparticle behaviour in vivo and the development of more effective nanoparticle therapeutics. Computational efforts are becoming an important tool in addressing both of these challenges, as well as in generally facilitating and accelerating nanotechnology-based translational research. The Nanoinformatics has come out as a new research area that covers raw data management, analysis of the data derived from biomedical applications and simulation of nanoparticle interactions with biological systems depicting the integration of biology, nanotechnology and informatics to form the basis for computational Nanomedicine.

Track 8: Research and Development of Nanomedicine

Nanomedicine has been developing rapidly in recent years, particularly in the development of novel Nano tools for medical diagnosis and treatment. For instance, a new trend is becoming prevalent in developing Nanosystems for simultaneous tumour diagnosis and therapy. A new terminology "Theranostics" has been frequently used and applied in pre-clinical research and trials. A Nanosystem can simultaneously achieve both cell targeted in vivo imaging and photothermal treatment of cancer. While achieving concurrent high spatial and temporal resolution of the lesions via cell targeting; special non-evasive treatments are implemented at the same time by various means, such as localized drug release, hyperthermia, and photo-thermal therapy. Inspired by these challenging problems in biomedical fields, the development of the nanotechnologies will be the key in addressing some of the critical issues in medicine, especially in early cancer diagnosis and treatment.

Track 9: Nanoparticles as precise Drug Delivery systems

With the remarkable development of Nanotechnology in recent years, new drug delivery approaches based on the state-of-the-art nanotechnology have been receiving significant attention. Nanoparticles, an evolvement of nanotechnology, are increasingly considered as a potential candidate to carry therapeutic agents safely into a targeted compartment in an organ, particular tissue or cell. These particles are colloidal structures with a diameter less than 1,000 nm, and therefore can penetrate through diminutive capillaries into the cell’s internal machinery. This innovative delivery technique might be a promising technology to meet the current challenges in drug delivery. The different types of nanoparticles drug delivery systems under investigation and their prospective therapeutic applications, and also present a closer look at the advances, current challenges, and future direction of nanoparticles drug delivery systems.

Track 10: Polymer Nanoparticles for Nanomedicine

The use of nanoscale materials and processes to address human disease is perhaps the most promising, considering that most complex downstream symptoms of disease are initiated by molecular level phenomena. Nanomedicine is defined as biological and medical intervention at the nanometer scale for the treatment, diagnosis, and increased understanding of biology and disease. Tremendous advances in the area of polymer synthesis and self-assembly have given rise to a new toolbox of engineered nanosized delivery and diagnostic agents that permit systemic and local administration, circulation in the bloodstream, and uptake and diffusion at the cellular and subcellular level.

Track 11: Design and Characterization of Nano Drug System

Recent years have witnessed the rapid development of inorganic nanomaterials for medical applications. At present, nanomedicines-nanoparticles (NPs) destined for therapy or diagnosis purposes-can be found in a number of medical applications, including therapeutics and diagnosis agents .Pushing the limits of nanotechnology towards enhanced Nanomedicines will surely help to reduce side effects of traditional treatments and to achieve earlier diagnosis. The interplay between engineered nanomaterials and biological components is influenced by complex interactions which make predicting their biological fate and performance a nontrivial issue. We hope that both early-stage and experienced researchers will find it valuable for designing nanoparticles for enhanced bio-performance. Nanoemulsions have attracted great attention in research, dosage form design and pharmacotherapy. This is as a result of a number of attributes peculiar to nanoemulsions.

Track 12: Toxicology of Nanoparticles

Nanotechnology is a rapidly growing field having potential applications in many areas. Nanoparticles have been studied for cell toxicity, immunotoxicity, and genotoxicity. Tetrazolium-based assays such as MTT, MTS, and WST-1 are used to determine cell viability. Different types of cell cultures, including cancer cell lines have been employed as in vitro toxicity models. Considering the potential applications of NPs in many fields and the growing apprehensions of FDA about the toxic potential of Nanoproducts, it is the need of the hour to look for new internationally agreed, free of bias toxicological models by focusing more on in vivo studies. The rapid expansion of nanotechnology promises to have great benefits for society, yet there is increasing concern that human and environmental exposure to engineered nanomaterials may result in significant adverse effects. The system was developed for Nanotoxicity assessment at single and multiple cell levels which can measure and compare the microscopic and macroscopic effects of nanoparticles interaction with cells, without interference from neighbouring cells' cues and also overall integrative effects produced by nanoparticles and cell–cell communication.

Track 13: Emerging Nanomedicine

Currently, the treatment of HIV requires regular oral dosage of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies. Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients

Track 14: Pharmaceutical Formulations

Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect. Formulation studies also consider such factors as particle size, polymorphism, pH, and solubility, as all of these can influence bioavailability and hence the activity of a drug.

Track 15: Applied Pharmaceutical sciences

Pharmacy is the science and technique of preparing and dispensing drugs. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. A theory relating chemical structure to pharmaceutical activity emerged from the interplay of experimental results from animal and human tests using vaccines, antitoxins, and antibodies with chemical knowledge about dyes and their molecular structures. Although pharmacology is essential to the study of pharmacy, it is not specific to pharmacy. Pharmacoinformatics is considered as another new discipline, for systematic drug discovery and development with efficiency and safety. The progressively more important role of the chemist and chemical science in pharmaceuticals in the early-20th century is mirrored in the history of the American Chemical Society's Division of Medicinal Chemistry

Track 16: Nanotechnology in Biology

Nanotechnology is enabling technology that deals with Nano- cadence sized objects. It's anticipated that nanotechnology will be developed at several situations accoutrements , bias and systems. The combination of biology and nanotechnology has led to a new generation of Nano bias that opens the possibility to characterize the chemical, physical, mechanical, and other molecular parcels. And it can be indeed used to characterize the single motes or cells at extraordinarily high outturn. Nanoparticles with distinctive chemical compositions, sizes, shapes, and face chemistries can be finagled fluently and this fashion has wide range of operations in natural systems. mileage of nanotechnology to biomedical lores indicate creation of accoutrements and bias designed to commerce insub-cellular scales with a high degree of particularity.

Track 17: Nanobubble in Nanomedicine

In recent times, microbubble and Nano bubble technologies have drawn great attention due to their wide operations in numerous fields of wisdom and technology, similar as water treatment, biomedical engineering, and nanomaterials. Nano bubbles parade unique characteristics; due to their nanosecond size and high internal pressure, they can remain stable in water for dragged ages of time. Nanobubbles can be created when gold nanoparticles are struck by short ray beats. The short- lived bubbles are veritably bright and can be made lower or larger by varying the power of the ray. Because they're visible under a microscope, nanobubbles can be used to either diagnose sick cells or to track the explosions that are destroying them.

Track 18: Nanosurgery

The main current operations of Nanotechnology for surgeons are in the areas of development of surgical implants using Nanomaterials, Imaging, Drug Delivery and development of Towel Engineering products, similar as pulpits with enhanced material – cell commerce. An illustration of this is the development of a altar for delivery of stem cells to replace imperfect retinal pigmented epithelial cells in age- related Macular Degeneration. In Dentistry exploration has been done, liposomal Nanoparticles that contained collagenase and performed tests with them in rats, and set up compared to conventional surgery, collagenase weakened the collagen filaments, making it easier to shift the teeth subsequently with braces.

Market Analysis

The global nanomedicine and drug delivery market has been expanding rapidly due to increasing demand for targeted therapies, precision medicine, and advanced treatment strategies. The global nanomedicine market was valued at approximately USD 210 billion in 2023 and is projected to reach nearly USD 440 billion by 2030, growing at a CAGR of around 10–11%. Meanwhile, the broader drug delivery systems market was estimated at about USD 1.6 trillion in 2024 and is expected to surpass USD 2.7 trillion by 2032, with a CAGR of nearly 7–8%.

Regionally, North America leads the market with nearly 40–45% share, followed by Europe (25–30%), while the Asia-Pacific region is the fastest-growing due to rising healthcare investments and biotechnology advancements. In terms of application, oncology accounts for nearly 35–40% of nanomedicine applications, followed by infectious diseases and cardiovascular disorders.

The rapid progress in nanotechnology, biotechnology, and pharmaceutical research is accelerating the development of smart drug delivery systems such as nanoparticles, liposomes, and nanocarriers. This growth highlights the importance of international conferences on Nanomedicine and Drug Delivery, which provide a platform for researchers and industry experts to share innovations, discuss clinical advancements, and promote global collaboration in this evolving field.